Sunshine Biopharma shares outstanding SBFM
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2025
- 18K
- On a year earlier
- +8714.2%
- more shares
Sunshine Biopharma had 18K diluted shares outstanding on average in Q2 FY25, the quarter to Jun 30, 2025.
That is 8714.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 8.2K | +13715% |
| FY2023 | 60 | +7% |
| FY2022 | 56 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY25 | 18K | +8714% | |
| Q1 FY25 | 13.5K | +8331% | |
| Q4 FY24 | 8.2K | +13715% | |
| Q3 FY24 | 6.3K | +9768% | |
| Q2 FY24 | 204 | −100% | |
| Q1 FY24 | 160 | +191% | |
| Q4 FY23 | 60 | +7% | |
| Q3 FY23 | 64 | +36% | |
| Q2 FY23 | 63.4K | +159842% | |
| Q1 FY23 | 55 | +318% | |
| Q4 FY22 | 56 | n/a | |
| Q3 FY22 | 47 | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sunshine Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.